Favorable prognostic factors in recurrent and metastatic melanoma

被引：53

作者：

Buzzell, RA ^{[1
]}

Zitelli, JA ^{[1
]}

机构：

[1] SHADYSIDE MED CTR,PITTSBURGH,PA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1996年 / 34卷 / 05期

关键词：

D O I：

10.1016/S0190-9622(96)90017-1

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Survival among patients with recurrent and metastatic melanoma varies widely. Several clinical and pathologic variables correlate with improved survival. Awareness of these favorable prognostic characteristics should assist in patient counseling and help identify those who may benefit from more aggressive therapeutic intervention.

引用

页码：798 / 803

页数：6

共 88 条

[41]

GOLDSMIT.HS, 1970, CANCER, V26, P606, DOI 10.1002/1097-0142(197009)26:3<606::AID-CNCR2820260317>3.0.CO

[42]

2-M

[43] LATE RECURRENCE OF STAGE-I MALIGNANT-MELANOMA [J].

GUTMAN, M ;

KLAUSNER, JM ;

INBAR, M ;

ROZIN, RR .

JOURNAL OF SURGICAL ONCOLOGY, 1989, 42 (02) :96-98

[44]

HEENAN PJ, 1992, CANCER-AM CANCER SOC, V69, P421, DOI 10.1002/1097-0142(19920115)69:2<421::AID-CNCR2820690224>3.0.CO

[45]

2-L

[46] EFFECT OF SURGICAL-TREATMENT ON STAGE-IV MELANOMA [J].

HENA, MA ;

EMRICH, LJ ;

NAMBISAN, RN ;

KARAKOUSIS, CP .

AMERICAN JOURNAL OF SURGERY, 1987, 153 (03) :270-275

[47]

KARAKOUSIS CP, 1994, SURGERY, V115, P295

[48]

KARAKOUSIS CP, 1983, CANCER-AM CANCER SOC, V52, P575, DOI 10.1002/1097-0142(19830801)52:3<575::AID-CNCR2820520333>3.0.CO

[49]

2-6

[50]

KARAKOUSIS CP, 1983, CANCER-AM CANCER SOC, V52, P1342, DOI 10.1002/1097-0142(19831001)52:7<1342::AID-CNCR2820520733>3.0.CO

← 1 2 3 4 5 6 7 8 9 →